Free Advance Live Sessions

In Conversation with COVID-19 Leaders

Leah Rosenbaum – Assistant Editor, Healthcare & Science, Forbes

Jeremy Levin – CEO, Ovid Therapeutics; Board of Directors Chair, Biotechnology Innovation Organization (BIO)

Michelle McMurry-Heath – President and CEO, Biotechnology Innovation Organization (BIO)

Register online to watch Part 2.

Country *

First Name *

Surname *

Company Name

Email *

Please tick these boxes if you do not wish to receive marketing information relevant to you from EBD Group

via Email

via Telephone

via Post

Please tick this box if you do not wish to be included on our third party mailing list to receive any related marketing communications from our third party partners

Gain access to four
COVID-19 conversations

Terms and Conditions | Privacy Policy

co-produced by:

We made four COVID-19 related sessions open to the public. Watch them now!

EBD Group Inc., 3150 Pio Pico Drive, Suite 201, Carlsbad, CA, 92008

Part 1:

The world according to COVID-19: From crisis to long-term impact

The path forward

Sara Jane Demy - CEO and Founder, Demy-Colton

Rick Bright - Former Director, Biomedical Advanced Research and Development Authority (BARDA), Transition Team, COVID-19 Advisory Board

COVID-19 therapeutics: A review of the options

In the balance: The humanitarian perspective – global policy

Jeremy Abbate, Publisher, Scientific American

Ruxandra Draghia-Akli, Global Head, Johnson & Johnson Global Public Health R&D

Amy Finan, CEO, Sabin Vaccine Institute

Richard Hatchett, CEO, CEPI

Stephen G. Brozak, Managing Partner and President, WBB Securities LLC

Prabhavathi Fernandes,Chair, National Biodefense Science Board

Michael Kurilla, Director of Division of Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health